Published in Vaccine Weekly, February 15th, 1999
The most difficult problem facing AIDS vaccine researchers is that they don't know what protective immunity to HIV looks like. Studies of highly exposed, uninfected individuals and of people who remain healthy despite long-standing HIV infection indicate that cell-mediated - and not antibody-mediated- immune responses are desirable.
Now a monkey study shows that antibodies can indeed protect against HIV infection and disease.
"An HIV vaccine that induces neutralizing antibodies should have a protective effect against HIV infection and disease," said Walter Reed Army Institute...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly